NASDAQ · Biotechnology
Ocugen Inc (OCGN)
$0.77
+4.79%
39
In band
Moving averages
SMA 200$1.40-45.15%
Company profile
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the development of gene therapies to cure diseases of blindness. The company is headquartered in Malvern, Pennsylvania.
SectorHealthcare
IndustryBiotechnology
Market cap$296.42M
P/E ratioNone
EPS$-0.20
Beta1.982
Dividend yield0.00%
52-week high$2.73
52-week low$0.69
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
DTIL
Precision Biosciences Inc
RSI 45
ALLO
Allogene Therapeutics Inc
RSI 19
AGEN
Agenus Inc
RSI 44
ARCT
Arcturus Therapeutics Holdings Inc
RSI 36
EDIT
Editas Medicine Inc
RSI 30
ALT
Altimmune Inc
RSI 23
RSI alerts for OCGN
An email when OCGN closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 6:58 AM EST